Close
Robin Mansukhani, CEO and Co-Founder of Deciduous
Robin Mansukhani, CEO and Co-Founder of Deciduous

Restoring immune biology to clear senescent cells

Timeline

2018

 - Founded

2019

 - Partnered 

Longevity.Technology, Harnessing the immune system to target cellular senescence - May 11, 2021

Deciduous Therapeutics
Deciduous Therapeutics

STAT, Reawakened immune cells show promise in mice against zombie cells tied to diseases of aging - May 10, 2021

Deciduous Therapeutics